In November 2024, the European Medicines Agency (EMA) recommended the licensing of lecanemab (Leqembi) for early...

Migraine is the second most prevalent neurological disorder (after tension-type headache), with a female-to-male ratio of...

Last year, the American Headache Society (AHS) issued a position statement update on the use of...

Over the last decade the incidence of ultiple sclerosis (MS) has increased by approximately 30 per...

A study has revealed significant therapeutic inertia in the treatment of women with multiple sclerosis (MS),...

The investigation of gene therapy for brain tumour-related epilepsy (BTRE) was among the topics discussed at...

The Nursing and Midwifery Board of Ireland (NMBI) has published its first ever State of Complaints...

Continuous intracerebroventricular (ICV) infusion of anaerobic dopamine (A-dopamine) is a feasible and safe treatment option for...

As of 1 June 2024, there were 89,496 nurses and midwives registered with the Nursing and...

The HSE has published findings from a survey examining the long-term impact of acute Covid-19. The...

The Irish Nurses and Midwives’ Organisation (INMO) has condemned the targeting of Kamal Adwan Hospital in...

Nurses in CareDoc and SouthDoc out-of-hours services have voted overwhelmingly in favour of industrial action over...